Human Oncology & Pathogenesis Program

The Ingo Mellinghoff Lab


Pictured: Ingo Mellinghoff
Ingo K. Mellinghoff, MD, FACP

Our laboratory focuses on the study of molecular pathways that regulate brain tumor growth. Our long-term goal is to develop therapeutic paradigms that target specific properties of primary brain tumors, including genetic alterations in cancer signaling pathways, unique aspects of brain tumor metabolism, or interactions of brain tumor cells with their brain microenvironment.  Our studies in experimental brain tumor models are closely linked to the evaluation of novel agents in early-phase clinical trials.

The Ingo Mellinghoff Lab


View All Publications


Pictured: Ingo Mellinghoff

Ingo K. Mellinghoff, MD, FACP

  • Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.
  • MD, Technical University Munich (Germany)
Office Phone
View physician profile
Physician profile


Lab Affilations


  • Member, Association of American Physicians (2020)
  • Member, American Society of Clinical Investigation (2013)
  • Advanced Clinical Research Award, American Society of Clinical Oncology (2009)
  • Clinical Scientist Development Award, Doris Duke Charitable Foundation (2008)
  • Translational Science Award, Sidney Kimmel Foundation (2008)
Read more
  • Distinguished Scientist, Sontag Foundation (2007)
  • Scholar, Forbeck Research Foundation (2005)
  • Young Investigator Award, American Society of Clinical Oncology (2003)

Open Positions

Career Opportunities

Apply now

Get in Touch